Leukaemia Trial, Recruiting NCT07450872 Sponsor: The Children's Hospital of Zhejiang University School of Medicine Condition: Leukaemia
Back to Leukaemia

Leukaemia Trial, Recruiting

NCT07450872
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For children/young people:

  • Children and young people between the ages of 8 and 18 years old
  • People who have been diagnosed with cancer (such as leukemia, lymphoma, brain or spinal cord tumors, or other solid tumors), confirmed by clinical and laboratory testing
  • People who are currently in the recovery or maintenance stage of their cancer treatment, or who finished treatment at least 6 months before joining the trial
  • People who are able to understand information, communicate, and fill out questionnaires on their own without assistance due to cognitive difficulties
  • People whose written agreement (and written agreement from their parent or legal guardian) has been obtained before joining

For caregivers:

  • People who are the main caregiver of a child enrolled in this trial
  • People aged 20 years or older
  • People who are able to read, understand, and complete questionnaires independently
  • People who have provided written consent before taking part

Who may not be able to join:

For children/young people:

  • People who have serious health problems caused by their cancer treatment (such as significant problems with organ function or the nervous system) that could affect how symptoms are measured
  • People who are unlikely to follow the study requirements or cannot complete interviews and questionnaires on their own
  • People who are already taking part in another clinical trial that involves a treatment or intervention that could affect this study's results
  • People who are expected to have major surgery, or start new chemotherapy or radiotherapy, during the time the study is running

For caregivers:

  • People who have experienced a major distressing life event in the past 6 months (such as the death of a loved one or a divorce) that could affect psychological assessments
  • People who have serious difficulties with thinking, memory, or understanding
  • People who have severe difficulties with speech, a psychiatric condition, or any other condition that would prevent them from completing assessments independently

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jinhu Wang, The Children's Hospital of Zhejiang University School of Medicine

Phone: 86+13606636547

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Children's Hospital of Zhejiang University School of Medicine
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Symptom Cluster Severity and Structure in Childhood Cancer Survivors

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov